3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Dermatologic
1
Conditions
Surgical Wound Infection
1
Skin Neoplasms
1
Postoperative Complications
1
Interventions
pembrolizumab
29
Nivolumab
29
Specimen Handling
24
Ipilimumab
19
Magnetic Resonance Spectroscopy
17
Biopsy
11
CTLA-4 Antigen
9
Opdualag
8
Cyclophosphamide
8
relatlimab
6
Paclitaxel
6
trametinib
5
fludarabine
5
cemiplimab
5
Carboplatin
5
fludarabine phosphate
4
dabrafenib
4
binimetinib
4
avelumab
4
HhAntag691
4
lifileucel
3
capivasertib
3
atezolizumab
3
aldesleukin
3
X-Rays
3
Temozolomide
3
Taxes
3
Surgical Procedures, Operative
3
Standard of Care
3
Pemetrexed
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Negative-Pressure Wound Therapy
×
Dermatologic
×
30 days
×
Clear all
NCT07040683
2026-05-28
LEGS
Region Skane
Phase NA
Recruiting
242 enrolled